VF
AVXL icon

Virtu Financial’s Anavex Life Sciences AVXL Stock Holding History

Virtu Financial’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,609
Closed -$63K – 1602
2026
Q1 		$63K Buy
+20,609
New +$89.3K ﹤0.01% 1252
2025
Q4 		– Sell
-12,859
Closed -$114K – 1658
2025
Q3 		$114K Buy
+12,859
New +$130K 0.01% 1022
2025
Q2 		– Sell
-25,895
Closed -$222K – 1445
2025
Q1 		$222K Sell
25,895
-64,139
-71% -$606K 0.01% 767
2024
Q4 		$967K Buy
+90,034
New +$693K 0.05% 309
2024
Q2 		– Sell
-40,612
Closed -$207K – 1302
2024
Q1 		$207K Buy
40,612
+18,954
+88% +$107K 0.02% 772
2023
Q4 		$202K Buy
+21,658
New +$149K 0.02% 822
2023
Q3 		– Sell
-11,507
Closed -$94K – 1294
2023
Q2 		$94K Sell
11,507
-56,858
-83% -$487K 0.01% 1052
2023
Q1 		$586K Buy
68,365
+38,751
+131% +$387K 0.06% 301
2022
Q4 		$274K Buy
+29,614
New +$316K 0.04% 532
2022
Q1 		– Sell
-15,523
Closed -$269K – 1490
2021
Q4 		$269K Buy
+15,523
New +$295K 0.03% 686
2021
Q3 		– Sell
-81,011
Closed -$1.85M – 1497
2021
Q2 		$1.85M Buy
+81,011
New +$1.2M 0.18% 84
2021
Q1 		– Sell
-15,050
Closed -$81K – 1588
2020
Q4 		$81K Sell
15,050
-15,696
-51% -$82.7K 0.01% 1114
2020
Q3 		$140K Buy
30,746
+17,843
+138% +$76.8K 0.02% 661
2020
Q2 		$63K Buy
+12,903
New +$48.8K 0.01% 974
2019
Q4 		$88K Sell
33,935
-16,504
-33% -$43.3K 0.01% 1105
2019
Q3 		$159K Buy
+50,439
New +$146K 0.01% 1015
2019
Q2 		– Sell
-49,580
Closed -$152K – 1452
2019
Q1 		$152K Buy
+49,580
New +$118K 0.01% 1064
2017
Q4 		– Sell
-24,671
Closed -$102K – 2354
2017
Q3 		$102K Buy
+24,671
New +$110K 0.01% 2072

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Virtu Financial's AVXL Position: Q2 2026 in Review

Virtu Financial sold out of Anavex Life Sciences (AVXL) in Q2 2026, closing a stake of 20,609 shares — an estimated $63K sold.

Virtu Financial first reported a position in AVXL in Q3 2017 and held it in 18 quarters. The position peaked at $1.85M in Q2 2021. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Virtu Financial reported no remaining Anavex Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 20,609 Anavex Life Sciences shares in Q2 2026, an estimated $63K.
  • Virtu Financial first reported a position in Anavex Life Sciences in Q3 2017 and held it in 18 quarters.
  • Virtu Financial's Anavex Life Sciences position peaked at $1.85M in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.